scholarly journals Role of Various Estrus Induction and Synchronization Protocols in Influencing Plasma Progesterone, Metabolic Profile and Fertility in Acyclic Buffaloes

2018 ◽  
Vol 14 (1) ◽  
Author(s):  
J. P. Prajapati ◽  
D. M. Patel ◽  
A. J. Dhami ◽  
J. A. Patel ◽  
K. K. Hadiya ◽  
...  
Keyword(s):  
Plasma Protein ◽  
Field Conditions ◽  
Control Group ◽  
Untreated Control Group ◽  
Time Intervals ◽  
Plasma Progesterone ◽  
Conception Rates ◽  
The Mean ◽  
Maximal Benefit

A study was carried out under field conditions on 50 acyclic/ anestrus buffaloes to evaluate the efficacy of four standard estrus synchronization protocols, viz., Doublesynch, Estradoublesynch, Ovsynch, and Ovsynch Plus (10 buffaloes in each protocol, and in untreated control group) in terms of estrus induction response, conception rates at induced estrus with FTAI and monitoring plasma progesterone, protein and cholesterol profile at different time intervals during treatment and day 12 post-AI. All the animals received pre-synchronization treatment, i.e., Inj. 100 mg ivermectin s/c, Inj. tono-vita 20 ml, and multi-minerals 1 bolus daily for 7 days. The conception rates obtained at induced estrus (FTAI) were 50.0, 40.0, 30.0 and 50.0 % with Doublesynch, Estradoublesynch, Ovsynch and Ovsynch Plus protocol, respectively. The rests were taken as non-conceived ones. The plasma progesterone concentrations monitored on day 0 (start of treatment), 7/9 (PGF2 α injection), 10/12 (FTAI) and on day 12 post-AI revealed significant (p Lass Than 0.01) effect of sampling days in all four protocols with higher values on day of PGF2 α injection and on day 12 post-AI compared to other days. Moreover, the plasma progesterone concentrations were significantly (p Lass Than 0.05) higher in conceiving than the non-conceiving buffaloes on day 12 post-AI in all 4 protocols. The mean plasma protein and cholesterol profile did not differ significantly between days in any of the protocols. The animals under Doublesynch protocol however had significantly higher protein values as compared to Ovsynch and Ovsynch Plus protocols. Moreover, the non-conceiving buffaloes under Ovsynch Plus protocol had significantly (p Lass Than 0.05) lower mean plasma protein (5.73±0.15 vs. 6.49±0.13 g/dl) and cholesterol (57.42±1.19 vs. 76.68±1.85 mg/dl) concentrations compared to their counterparts. It was concluded that all four hormonal protocols improved plasma progesterone profile and conception rates in acyclic buffaloes without altering plasma protein and cholesterol profile. The maximal benefit was with Doublesynch and Ovsynch plus protocols, hence these can be practiced under field conditions to manage acyclic buffaloes.

Ovarian Dynamics, Plasma Endocrine Profile and Fertility Response Following Synchronization Protocols in Crossbred Cows with Cystic Ovaries

2020 ◽  
Author(s):  
A. J. Dhami ◽  
J. H. Chauhan ◽  
K. K. Hadiya ◽  
N. P. Sarvaiya
Keyword(s):  
Estrogenic Activity ◽  
Treatment Modalities ◽  
Ovarian Cysts ◽  
Control Group ◽  
Therapeutic Success ◽  
Plasma Progesterone ◽  
Lh Surge ◽  
Crossbred Cows ◽  
Conception Rates ◽  
The Mean

Background: Cystic ovarian degeneration (COD) with prevalence of 10-13% is a common and economically important condition in dairy cattle affecting fertility. Predisposing factors and aetiology of ovarian cysts are multifaceted. The most widely accepted cause is either absent, insufficient or wrong time occurrence of pre-ovulatory LH-surge. The accuracy of differential diagnosis of cyst per rectum can be increased by simultaneous use of USG and/or plasma progesterone assay and therapeutic success depends on type and duration of cystic condition. The literature on these aspects in crossbred cows is meagre, hence was planned to differentially diagnose the ovarian follicular and luteal cysts based on clinical, sonographic and endocrine findings and to study the estrus response and conception rates following different treatment modalities of COD in crossbred cattle. Methods: This study was conducted on greater than 90 days postpartum HF crossbred cows with cystic ovaries (n=58) confirmed by per rectal palpation and ultrasonography. The animals with follicular cysts were randomly treated with either conventional Ovsynch or Ovsynch + CIDR protocol (n=10 each) and those with luteal cysts with either Double PG injections 11 days apart or modified Ovsynch protocol (n=16 each) with fixed time AI. A group of six cystic cows was kept as untreated control. Blood samples were collected in heparinized vacutainers, together with trans-rectal ultrasonography, on day 0 (just before initiation of treatment), on day of last PGF2á injection, on day of induced estrus/FTAI and on day 12 post-AI for determination of plasma progesterone and estradiol-17â by RIA technique. Results: The mean diameters and wall thickness of ovarian cysts regressed significantly (p less than 0.01) among responded cows of all four protocols. The estrus induction response within 48-96 hrs of last PG injection with Ovsynch, Ovsynch + CIDR, Modified Ovsynch and Double PG protocols was 90.00, 100.00, 87.50 and 81.25 %, respectively. The conception rates at induced estrus with FTAI for these protocols were 50.00, 40.00, 50.00 and 43.75 %, respectively and the corresponding overall conception rates for 3 cycles’ post-treatment were 60.00, 70.00, 68.75 and 56.25 %, respectively, compared to zero result of control group. The mean plasma progesterone concentration varied highly significantly (p less than 0.01) between periods of treatment in all protocols, the values were lower (p less than 0.01) on day 0 and on day of FTAI than on the day of last PG injection and on day 12 post-AI. The values on day 12 post-AI were significantly higher in conceived than non-conceived cows. The trend of estradiol-17â profile on day of last PG injection was reversed than on day 0. The higher levels of estradiol-17â on day of FTAI were associated with regression of cystic structures and development of new dominant follicles with estrogenic activity concomitant to induced estrus and ovulatory LH surge in most of the animals as evident from USG monitoring, behavioural signs and conception rates.

Effect of estrus synchronization on plasma progesterone profile and fertility response in postpartum suckled anestrous Kankrej cows

2016 ◽  
Author(s):  
Mehrajuddin Naikoo ◽  
A. J. Dhami ◽  
Ammu Ramakrishnan
Keyword(s):  
Control Group ◽  
Ovarian Activity ◽  
Treatment Protocols ◽  
Plasma Progesterone ◽  
Mean Values ◽  
Cyclic Groups ◽  
Early Postpartum ◽  
Conception Rates ◽  
Cyclic Control ◽  
The Mean

The study was designed at evaluating early postpartum ovarian activity through plasma progesterone profile at 10 days interval up to 90 days, followed by induction of estrus in postpartum anestrous suckled Kankrej cows (n=18) using Ovsynch, CIDR and Ovsynch + CIDR treatment protocols with FTAI (6 cows in each protocol), keeping six normal cyclic cows as control. The plasma P4 profile (ng/ml) varied in the range of 0.15±0.03 to 1.70±0.80 in treatment groups and 0.62 ±0.19 to 4.09±1.60 in control group up to 90 days postpartum. The mean P4 concentration on the day of calving was low (<1 ng/ml) in all the groups, which gradually increased to reach peak levels by day 40 in cyclic control (4.09±1.60 ng/ml), Ovsynch (1.70±0.80 ng/ml) and CIDR (1.68±0.47 ng/ml) and by day 20 in Ovsynch + CIDR (1.09±0.23 ng/ml) groups. Most of the cows turned into subestrous or anestrous condition between days 40 and 90 postpartum. The estrus induction response in Ovsynch, CIDR and Ovsynch + CIDR groups initiated at day 90-92 postpartum was 66.66, 83.33 and 50.00 per cent, respectively. The conception rates at induced estrus were 16.66, 33.33 and 16.66 per cent, and overall of 3 cycles 33.33 (2/6), 50.00 (3/3) and 33.33 (2/6) per cent, respectively. In normal cyclic control group, the conception rates at first cycle and overall of 3 cycles were 33.33 and 50.00 per cent. The mean plasma P4 (ng/ml) concentrations were significantly (P<0.05) higher on day 7 in Ovsynch (1.41 ±0.10), CIDR (4.92±0.83) and Ovsynch + CIDR (3.87±0.84) protocols as compared to their corresponding values on day 0 and day 9/10 (AI). The mean values of plasma P4 from days 20 to 40 post-AI were higher in conceived cows than in non-conceived cows of CIDR and Ovsynch + CIDR groups, compared to the animals in Ovsynch and normal cyclic groups. It is opined that the use of different protocols, mainly CIDR, may serve as an effective tool for induction and synchronization of estrus and improvement of conception rate in postpartum anestrous suckled Kankrej cows.

Studies in the augmentation of fertility of Romney ewes with pregnant-mare serum

1954 ◽  
Vol 45 (1) ◽  
pp. 60-79 ◽  
Author(s):  
L. R. Wallace
Keyword(s):  
Single Injection ◽  
Strain Differences ◽  
Oestrous Cycle ◽  
Control Group ◽  
Untreated Control Group ◽  
Normal Order ◽  
Conception Rates ◽  
Cycle Lengths ◽  
The Mean ◽  
Breeding Seasons

In the course of two breeding seasons 261 mature Romney ewes have been employed in three slaughter experiments designed to investigate the manner in which the reproductive performance of such animals, after treatment with a single injection of P.M.S., is conditioned by: (a) the amount of P.M.S. administered; (b) the nutritive status of the treated animals; (c) the stage of the oestrous cycle at which the P.M.S. is administered.In the first experiment, one untreated control group and three experimental groups of ewes, treated with different amounts of P.M.S., on the twelfth and thirteenth days of the cycle, were used to establish a dose level-ovulation response relationship. Mean ovulation rates and ranges of ovulations observed were: control 1.17 (1–2); 250 i.u. P.M.S. 1.50 (1–2); 500 i.u. P.M.S. 2.07 (1–3); 1000 i.u. P.M.S. 4.33 (1–13).In the second experiment, oestrous cycle lengths, ovulation and conception rates, and loss of ova during the first few weeks of pregnancy were compared in four groups of ewes that had been treated as follows: (a) neither flushed nor treated with P.M.S.; (b) flushed but not treated with P.M.S.; (c) not flushed but treated with 650 i.u. P.M.S. on the twelfth or thirteenth days of the cycle; (d) flushed and treated with 650 i.u. P.M.S. on the twelfth or thirteenth days of the cycle.Oestrous cycle lengths were of significantly shorter duration in flushed than in unflushed ewes (0.5 day) and in P.M.S.-treated than in untreated animals (0.7 day). Conception rates were of a normal order in all four groups. The mean ovulation rates of those that conceived at first fertile service were respectively 1.33, 1.61, 1.80 and 1.88. The number of ovulations ranged from 1–2 in the unflushed–untreated group and from 1–3 in each of the other three groups.In the third experiment results obtained from groups of ewes treated with 650 i.u. P.M.S. on the tenth, eleventh, twelfth, thirteenth and fourteenth days respectively, were compared. Mean ovulation rates were approximately similar in all five groups, but (as was also the case in the second experiment) of a lower order than might have been expected from the dose response curve established in the first experiment. Conception rates were satisfactory after injection on the twelfth, thirteenth or fourteenth days, but unsatisfactory after treatment on the eleventh day, and still less satisfactory after treatment on the tenth day.From the results obtained in these three experiments the following general conclusions were drawn:(1) Breed or strain differences may be of considerable importance in governing the extent of the ovulation response following P.M.S. treatment.(2) The magnitude of the ovulation response to P.M.S. treatment depends to some extent on the ‘batch’ of P.M.S. used and/or the strain of ewes employed.(3) The nutritive status of ewes during the breeding season is not an important factor in determining the ovulation rate following P.M.S. treatment.(4) When P.M.S. is administered 5 days or less before the onset of the subsequent oestrus, good conception rates are obtained.(5) Extremely poor conception rates result where animals are treated more than 5 days before oestrus.(6) Best ovulation and conception rates are obtained when the treatment-to-oestrus interval is 2–3 days.(7) For optimum results, treatment on the fourteenth day of the cycle is recommended. However, good results are also obtained after treatment on either the twelfth or the thirteenth days. Treatment on the fifteenth day should also be reasonably satisfactory.(8) When ovulated in similar numbers, and provided conception occurs, ova produced as a result of P.M.S. stimulation are no more prone to fail to undergo normal embryonic development than are naturally ripened eggs.

scholarly journals Early Neuromuscular Blockade in Children with Pediatric Acute Respiratory Distress Syndrome

2020 ◽  
Vol 09 (03) ◽  
pp. 201-206
Author(s):  
Surabhi Chandra ◽  
Sahil Goel ◽  
Ritika Dawra
Keyword(s):  
Mechanical Ventilation ◽  
Acute Respiratory Distress Syndrome ◽  
Respiratory Distress Syndrome ◽  
Neuromuscular Blockade ◽  
Distress Syndrome ◽  
Control Group ◽  
Case Group ◽  
The Mean ◽  
Mean Time

AbstractPediatric acute respiratory distress syndrome (PARDS) is a challenging problem with high mortality. Role of neuromuscular blockade in the management of ARDS to date has been controversial, and this study was done to study the role of neuromuscular blockade in children having PARDS and development of associated complications, if any. This was a prospective, case–control study conducted in the pediatric intensive care unit (PICU) of a tertiary care teaching hospital, over a period of 24 months. Patients of age 1 to 18 years who presented with or developed PARDS during their course of hospitalization were included after written informed consent was obtained from their parents and/or guardians. Patients with PARDS requiring invasive mechanical ventilation were partitioned into a case group and a control group. Case group patients were sedated and paralyzed using midazolam (1 µg/kg/min) and vecuronium (1 µg/kg/min), respectively, along with institution of definitive management. Control group patients were given definitive and supportive therapy, but no neuromuscular blocking agents (NMBAs). All patients were followed up for signs and symptoms of myopathy or neuropathy during the entire duration of hospital stay and up to 3 months after discharge. During the study period, 613 patients were admitted to the PICU of which 91 patients qualified as having PARDS. Sepsis was the main etiology in 67 of the 91 patients (73.6%) with PARDS. Fifty-nine patients were included in the study, of which 29 patients were included in the case group and 30 patients were included in the control group. Among the 29 case group patients, 25 patients (86.2%) were successfully extubated. Four patients from the case group expired, while 14 out of 30 control group patients (46.7%) expired. Hypotension was present in 26 case group patients (89.6%), of which all showed resolution within 48 hours of definitive treatment. The mean time to resolution of hypotension was 41.6 hours (standard deviation [SD]: 5.759; range: 24–48) for case group patients, significantly lower (p < 0.0001) than the mean time to resolution of 103 hours (SD: 18.995; range: 90–126) for the 10 control group patients with hypotension that survived. Mean oxygenation index (OI) following 48 hours of vecuronium therapy was significantly lower (p < 0.0001; 95% confidence interval: 5.9129–9.9671) than mean OI at admission for case group patients. None of the patients receiving vecuronium exhibited neuromuscular deficit during their hospital stay, at time of discharge, or at follow-up evaluation up to 3 months after discharge. In this study, pediatric cases diagnosed with PARDS and managed with mechanical ventilation and vecuronium therapy had improved mean OI following 48 hours of NMBA therapy and a lower mortality when compared with matched control group patients. Incidence of NMBA-related weakness was not commonly observed in these patients.

scholarly journals Association Between Osteoarticular Scores and Acute Phase Reactant Levels in Rheumatoid Arthritis

2009 ◽  
Vol 28 (2) ◽  
pp. 116-121 ◽  
Author(s):  
Irena Kafeđiska ◽  
Dejan Spasovski ◽  
Todor Gruev ◽  
Mane Grličkov ◽  
Kočo Cakalaroski ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Acute Phase ◽  
Acute Phase Reactant ◽  
Control Group ◽  
Time Intervals ◽  
Acute Phase Reactants ◽  
Mean Values ◽  
Cell Counts ◽  
Phase Reactant ◽  
The Mean

Association Between Osteoarticular Scores and Acute Phase Reactant Levels in Rheumatoid Arthritis The aim of this prospective control study was a quantitative evaluation of the activity of rheumatoid arthritis (RA) in certain time intervals, using articular indexes (set of 28 sensitive and 28 swollen joints), laboratory parameters (Hb, Hct, Er, Le and Plt) and acute phase reactants (ESR, RF, CRP); to determine which of the acute phase reactants is the most useful biochemical marker for the evaluation of disease activity in RA; to quantify the therapeutical and laboratory differences in certain time intervals in the group with and without immunomodulatory therapy with Methotrexate. Sixty patients with RA were included, 27 of who were treated with non-steroid antiinflammatory drugs (NSAIDs) and Methotrexate (MTX). The control group consisted of 33 patients treated only with NSAIDs because of irregular controls. In the first group of patients the disease activity was estimated at four time intervals, and in the control group of patients at three time intervals following the scores of the articular indexes, blood cell counts, ESR and CRP in every patient. In the first group of patients decreased activity of RA was found upon every following control with a consecutive decrease in mean values of the scores of articular indexes with statistically significant differences at the four time intervals. Considering laboratory parameters, there were statistically significant differences in the mean values of Hb, Er, Plt, ESR, (p=0.0462, p=0.0076, p= 0.0058, p= 0.0003). Mean values of CRP did not show statistically significant differences, but the number of patients who were CRP negative increased (there were great standard deviations). In the group of patients treated only with NSAIDs, there were statistically significant differences in the mean values of the scores of articular indexes with an increse at every following control (in favour of progression of the disease). There were no statistically significant differences considering blood cell counts, ESR and CRP (in favour of permanently active disease). In conclusion, CRP is the most useful marker for the prospective follow-up of patients with RA.

scholarly journals A Rapid and Effective Method to Prolong Pain Relief in Sheep Using Bupivacaine and Intralipid ® Combination

2019 ◽  
Vol 4 (3) ◽  
pp. 1-6
Author(s):  
Farzin Sahebjam
Keyword(s):  
Nerve Block ◽  
Final Concentration ◽  
Noxious Stimulus ◽  
Control Group ◽  
Multiple Time ◽  
Treatment Results ◽  
Time Intervals ◽  
Nerve Blocks ◽  
Duration Of Action ◽  
The Mean

Background : To compare the duration of action of a local anesthetic block using a lipid formulation of bupivacaine to the commercially available aqueous formulation. Bupivacaine 0.5% was mixed with an equal volume of either lipid emulsion (Intralipid, Fresenius Kabi) or normal saline resulting in a final concentration of 0.25% bupivacaine. Eighteen sheep were administered a n erve block of either control or treatment at the metacarpal region of each forelimb to compare the efficacy of the injected formulations. The nociceptive test was determined by applying a blunt noxious stimulus to the foot below the nerve block at multiple time intervals until the sheep responded by withdrawing its foot. The person assessing the response to the noxious stimulus was blinded to the treatment. Results: The Intralipid formulation significantly extended the duration of the nerve block compared to the control group. The mean analgesic period (mean±SD) in the control legs was 4.23±1.8 hr. compared to 5.81±1.78 hr. in the Intralipid injected legs (p=0.013). Conclusions : In conclusion, an Intralipid® - based formulation provided a more prolonged dura tion of local anesthesia after nerve blocks in the sheep metacarpal region compared to aqueous bupivacaine.

scholarly journals The Role of Mannose-Binding Lectin Serum Level in Tubotympanic Chronic Suppurative Otitis Media

2018 ◽  
Vol 2018 ◽  
pp. 1-4
Author(s):  
Anton Budhi Darmawan ◽  
Marsetyawan H. N. E. Soesatyo ◽  
Ratna Dwi Restuti ◽  
Agus Surono
Keyword(s):  
Serum Level ◽  
Otitis Media ◽  
Control Group ◽  
Suppurative Otitis Media ◽  
Mannose Binding ◽  
The Mean ◽  
And Control ◽  
Binding Lectin ◽  
Mbl Deficiency

Background. Chronic suppurative otitis media (CSOM) is a common public health problem worldwide and a major cause of hearing impairment especially in developing countries. The role of Mannose-Binding Lectin (MBL), a component of innate immunity, in CSOM has not been studied. The aim of the study was to examine whether MBL deficiency was more frequently present in cases group of tubotympanic CSOM patients rather than healthy subjects. Material and Methods. This was an analytic observational study. Subjects were enrolled in the Otorhinolaryngology Clinic at Margono Soekarjo Hospital, Purwokerto, Indonesia. An independent t-test was used to compare the mean of MBL serum concentration between tubotympanic CSOM subjects and control. Results. From 36 tubotympanic CSOM patients, there were 8 (22.22%) patients with MBL deficiency (MBL level < 100 ng/ml), while no deficiency was found in the control group. The mean of MBL level in cases group was 354.88 ng/ml, with the lowest level being 0.001 ng/ml and the highest level 690.24 ng/ml, while in the control group MBL level mean was 376.27 with the lowest level being 188.71 and the highest level 794.54 ng/ml. Conclusion. There was no significant difference of MBL serum level between tubotympanic CSOM and control group. However, the presence of subjects with MBL deficiency in the tubotympanic CSOM group might be considered as playing a role in the tubotympanic CSOM.

scholarly journals Manuka Honey versus Antibiotic Ear Drops in Healing of Post-Operative Mastoid Cavity: A Prospective Randomized Trial

2020 ◽  
Vol 63 (5) ◽  
pp. 199-205
Author(s):  
Niveditha Damodharan ◽  
Roshan Kumar Verma ◽  
Archana Angrup ◽  
Jaimanti Bakshi ◽  
Naresh K Panda
Keyword(s):  
Chronic Otitis Media ◽  
Mastoid Cavity ◽  
Control Group ◽  
Study Group ◽  
Manuka Honey ◽  
Sterile Culture ◽  
Canal Wall Down ◽  
Canal Wall Down Mastoidectomy ◽  
The Mean

Background and Objectives This study investigates the role of manuka honey in the healing of postoperative mastoid cavity.Subjects and Method This was a single centre prospective study on 40 consecutive patients of chronic otitis media undergoing canal wall down mastoidectomy. Manuka honey soaked in gel foam was kept in the mastoid cavity for the study group and antibiotic soaked gel foam was kept for the control group. Culture swabs from mastoid granulations were sent at various times from both groups. The healing of the mastoid cavity was assessed in the follow up period.Results Preoperatively 15 out of 20 patients (75%) had a positive aural swab culture in the study group while 11 out of 20 (55%) in the control group had a positive aural swab culture. The most common organism isolated was <i>Pseudomonas aeruginosa</i> and <i>Proteus mirabilis</i>. One month after mastoidectomy only 4 patients (20%) had sterile culture and 16 patients (80%) had grown organisms; in the control group, 7 patients (35%) had sterile culture and 13 patients (65%) had growth on culture. The mean merchant scores for the study group and the control were 2.61 (2-5) and 2.05 (1-4), respectively. At 3 months 13 patients (65%) with sterile culture and 7 patients (35%) had growth on culture; in the control group, 16 patients (80%) had sterile culture and 4 had shown persistent growth on culture (<i>p</i>=0.28). All positive cultures were aerobic in both groups. The mean merchant scores for the study group and the control were 1.03 (0-4) and 0.7 (0-3), respectively (<i>p</i>=0.09).Conclusion Healing of mastoid cavity was almost similar in both groups (<i>p</i>>0.05). Manuka honey exhibited antibacterial activity against <i>Pseudomonas</i>, <i>Proteus</i>, <i>Klebsiella</i>, <i>Escherichia coli</i>, <i>Staphylococcus</i>.

Importance of the FcγRIIa-Arg/His-131 Polymorphism in Heparin-induced Thrombocytopenia Diagnosis

1998 ◽  
Vol 79 (03) ◽  
pp. 523-528 ◽  
Author(s):  
Raphaël Saffroy ◽  
Dominique Lasne ◽  
Gilles Chatellier ◽  
Martine Aiach ◽  
Francine Rendu ◽  
...  
Keyword(s):  
Serotonin Release ◽  
Positive Answer ◽  
Control Group ◽  
Normal Donor ◽  
Heparin Induced Thrombocytopenia ◽  
Weak Association ◽  
Healthy Control ◽  
Release Assay ◽  
The Mean

SummaryHeparin-induced thrombocytopenia (HIT) involves heparin-dependent antibodies which induce platelet activation. In the present study, we searched for a relationship between the polymorphism of the Fc receptor (FcγRIIa) and the development of HIT. In this purpose, all the donors were genotyped for their FcγRIIA and HIT patients were selected on the basis of at least one positive answer by 14C-serotonin release assay (SRA). The frequency distribution of the FcγRIIa polymorphism in the HIT patient group was similar to that observed in the healthy control group. Moreover, a statistical analysis taking into account our results and those of 3 previously published studies, suggested at most only a weak association between HIT and the FcγRIIa-131 polymorphism.Laboratory tests used to diagnose HIT rely on the activation of normal donor platelets but fail to detect every HIT positive patient. We determined the role of FcγRIIa-131 polymorphism on the reactivity of control platelets to HIT plasmas. When control platelet FcγRIIa-131 was of Arg/Arg form, only 47% of the HIT plasmas were positive by SRA, compared to 81% and 74% for His/His or His/Arg forms, respectively. We also compared the level of anti PF4/heparin antibodies in the HIT plasmas with the response obtained by SRA. The mean anti PF4/heparin antibodies level in HIT plasma was significantly lower in negative SRA than in positive tests when using control platelets from FcγRIIa-Arg/Arg131 and heterozygous donors. Thus, the variability of control platelets to respond to HIT plasmas in the SRA test is related to both the FcγRIIa-131 polymorphism, and to the amount of anti PF4/heparin antibodies.

Abstract WP92: Neutrophil-lymphocyte Ratio in Cerebral Aneurysm

Stroke ◽  
2016 ◽  
Vol 47 (suppl_1) ◽  
Author(s):  
Kee Ook Lee ◽  
Kyung-Yul Lee ◽  
Jae-Youn Kim ◽  
Cheol-Young Lee ◽  
Sang-Jun Na ◽  
...  
Keyword(s):  
Cerebral Aneurysm ◽  
Control Group ◽  
Neutrophil Lymphocyte Ratio ◽  
Lymphocyte Ratio ◽  
Patients With Cancer ◽  
The Mean ◽  
Artery Disease ◽  
Wbc Count ◽  
And Control

Introduction: Blood neutrophil/lymphocyte ratio (NLR) is a simple marker of subclinical inflammation that can be easily obtained. The NLR has recently emerged as a prognostic marker in patients with cancer and coronary artery disease. However, little is known about the role of NLR in patients with intracranial aneurysm (IA). Hypothesis: The purpose of this study was to determine the clinical significance of NLR in patients with IA. Methods: The study group consisted of patients with IA who had been admitted to the neurology department from January 2008 to December 2014. A total of 362 patients including 176 patients with unruptured IA, 186 patient with ruptured IA were enrolled in this study. The control group consisted of 178 age, sex-matched healthy adults who had not harbor IA by CTA, MRA, DSA. The baseline NLR was calculated as the ratio of neutrophil count to lymphocyte count. WBC count>12.000 cells per μL or <4.000 cells per μL and high body temperature>38 ° are excluded from the study. Results: The Mean NLR was significantly higher among persons with cerebral aneurysm compared with controls (P < 0.001). The level of NLR in ruptured IA group were found higher compared to unruptured IA and control group (7.0 ± 6.6 vs 2.5 ± 1.5 vs 1.6 ± 0.5, P < 0.001). Other comorbid conditions were balanced between these three groups. Conclusions: Higher NLR is associated with cerebral aneurysm. Unlike many other inflammatory markers and bioassays, NLR are inexpensive and readily available biomarkers that may be useful for risk stratification in patients with cerebral aneurysm.

Sign in / Sign up

Export Citation Format

Share Document